Stanford Cancer Institute; Hematology — Palo Alto, California

Stanford Cancer Institute; Hematology is a clinical research site located in Palo Alto, California, United States 94305.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Stanford Cancer Institute; Hematology has participated in 1 clinical trials.

Therapeutic areas: Solid Tumor.

Sponsors: Hoffmann-La Roche.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Stanford Cancer Institute; Hematology?

Stanford Cancer Institute; Hematology has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Stanford Cancer Institute; Hematology conducted?

Stanford Cancer Institute; Hematology has 1 clinical trials on record. Their work covers Solid Tumor.

Is Stanford Cancer Institute; Hematology accredited by Crixeo Health?

Stanford Cancer Institute; Hematology has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Stanford Cancer Institute; Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.